CCT301 CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCT301 CAR-T, covering 2024-10-28 to 2024-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma [Phase 1, Phase 2]